1 严惠芳, 陈瑞婷, 周金煦, 祥鄂.抗肿瘤药物实验法[A].见:徐叔云, 卞如濂, 陈修, 主编.药理实验方法学[M].第3 版.北京:人民卫生出版社, 2002:1757-84 2 马旭升, 李玉富, 牛青霞.实验肿瘤研究[A].见:吴细丕, 钱林法, 主编.实验动物与肿瘤研究[M].北京:中国医药科技出版社, 2000:112-6 3 叶明霞, 周顺长, 孔利佳, 任大宏.S180 肉瘤, 艾氏腹水瘤肿瘤移植模型建立的研究[J].中国实验动物学杂志,2002;12(1):14-6 4 刘斌.肿瘤细胞的取材及培养[A].见:司徒镇强, 吴军正, 主编.细胞培养[M].修订版.西安:世界图书出版公司, 2004:189-91 5 DeVita VT Jr.The relationship between tumor mass and resistance to chemotherapy.Implications for surgical adjuvant treatment of cancer[J].Cancer, 1983;51(7):1209-20 6 Yamamura Y, Nakajima T, Ohta K, Nashimoto A, Arai K, Hiratsuka M, et al.Determining prognostic factors for gastric cancer using the regression tree method[J].Gastric Cancer, 2002;5(4):201-7 7 Van Laar JA, Rustum YM, Van der Wilt CL, Smid K, Kuiper CM, Pinedo HM, et al.Tumor size and origin determine the antitumor activity of cisplatin or 5-fluorouracil and its modulation by leucovorine in murine colon carcinomas[J].Cancer Chemother Pharmacol, 1996;39(1-2):79-89 8 Milas L, Ito H, Hunter N.Effect of tumor size on S-2-(3-aminopropy lamino)ethylphorothioic acid and misonidazole alteration of tumor respose to cyclophosphamide[J].Cancer Res, 1983;43 (7):3050-6 9 Wenger FA, Jacobi CA, Zieren J, Docke W, Volk HD, Muller JM.Tumor size and lymph-node status in pancreatic carcinoma is there a correlation to the preoperative immune function[J]. Langenbecks Arch Surg, 1999;384(5):473-8 |